Ascentage Pharma Group International (AAPG) Total Liabilities (2022 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Total Liabilities for 4 consecutive years, with $370.7 million as the latest value for Q4 2025.
- For Q4 2025, Total Liabilities rose 13.62% year-over-year to $370.7 million; the TTM value through Dec 2025 reached $370.7 million, up 13.62%, while the annual FY2025 figure was $376.0 million, 17.1% up from the prior year.
- Total Liabilities hit $370.7 million in Q4 2025 for Ascentage Pharma Group International, up from $326.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $370.7 million in Q4 2025 and bottomed at -$57.5 million in Q4 2022.
- Average Total Liabilities over 4 years is $244.2 million, with a median of $331.9 million recorded in 2023.
- Year-over-year, Total Liabilities surged 687.31% in 2023 and then decreased 3.32% in 2024.
- Ascentage Pharma Group International's Total Liabilities stood at -$57.5 million in 2022, then soared by 687.31% to $337.5 million in 2023, then dropped by 3.32% to $326.3 million in 2024, then increased by 13.62% to $370.7 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods came in at $370.7 million, $326.3 million, and $337.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.